Long Hill Capital Management is a venture capital firm investing in high growth technology and healthcare companies in China.
Business Model:
Revenue: $0
Employees: 0-0
Address: 1266 Nanjing West Road
City: Shanghai
State: other
Zip: 200040
Country: CN
Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese. Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates (NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor. Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2021 | InCarey | Series C | 0 |
3/2020 | StoneWise | Series A | 10M |
4/2021 | StoneWise | Series B | 100M |
3/2022 | Various Technology | Series A | 7.9M |
12/2017 | Orient Speech Therapy Center | Series B | 25M |
10/2018 | Lab in One | Series A | 1.9M |
6/2022 | BANGBANG ROBOT | Series B | 0 |
6/2021 | Orient Speech Therapy Center | Series C | 60M |
3/2010 | MORE Health | Angel Round | - |
8/2022 | Lab Direct | Series A | 10M |
12/2022 | Wangli Technology | Venture Round | 14.4M |
9/2022 | BestCovered | Series A | - |
11/2018 | VCBeat | Series A | 2.9M |
11/2016 | Pinetree | Series B | 20M |
9/2020 | InCarey | Series B | 30M |
8/2018 | Y-Med | Series A | 1.5M |
3/2022 | Aibo Medical Robot | Seed Round | 18.9M |
11/2021 | UP Clinic | Series B | - |
12/2021 | Jiandanxinli (aka Simple Psychology) | Series B | 0 |
10/2021 | Haoyishu | Series A | 7.8M |
2/2021 | Orient Speech Therapy Center | Series C | 23M |
6/2022 | BANGBANG ROBOT | Series B | 0 |
3/2022 | Aibo Medical Robot | Seed Round | 0 |
3/2022 | Various Technology | Series A | 0 |
12/2021 | InCarey | Series C | 0 |
12/2021 | Jiandanxinli (aka Simple Psychology) | Series B | 0 |
11/2021 | UP Clinic | Series B | - |
10/2021 | Haoyishu | Series A | 0 |
6/2021 | Orient Speech Therapy Center | Series C | 0 |
4/2021 | StoneWise | Series B | 0 |
2/2021 | Orient Speech Therapy Center | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|